Sri Indu Drugs India Private Limited
Produces and sells industrial chemicals, including basic chrome sulfate, poly aluminum chloride, and chromium sulfate.
2009 | Hyderabad, Telangana (India) | Active
Sri Indu Drugs India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 70.44%
- Profit Growth 532.54%
- Ebitda 60.11%
- Net Worth 421.99%
- Total Assets 59.73%
About Sri Indu Drugs India
Sri Indu Drugs India Private Limited (SIDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 August 2009 and has a history of 15 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Govina Ramakrishna, Indu Govina, and Rahul Tammineedi serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2009PTC064701
- Company No.
064701
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Chemicals and Materials
What products or services does Sri Indu Drugs India Private Limited offer?
Sri Indu Drugs India Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Inorganic Salts, Water Coagulant, Poly Aluminium Chloride.
Sri Indu Drugs India Private Limited
Explore comprehensive data for Sri Indu Drugs India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Sri Indu Drugs India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govina Ramakrishna  | Director | 10-Aug-2009 | Current |
| Indu Govina | Director | 10-Aug-2009 | Current |
| Rahul Tammineedi | Additional Director | 29-Aug-2022 | Current |
Financial Performance of Sri Indu Drugs India.
Sri Indu Drugs India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 70.44% increase. The company also saw a substantial improvement in profitability, with a 532.54% increase in profit. The company's net worth Soared by an impressive increase of 421.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Indu Drugs India?
In 2023, Sri Indu Drugs India had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Indu Drugs India?
Unlock and access historical data on people associated with Sri Indu Drugs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Indu Drugs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Indu Drugs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sri Indu Drugs India
Recent activity within the organization
- Annual General Meeting
Sri Indu Drugs India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Sri Indu Drugs India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Rahul Tammineedi was appointed as a Additional Director was appointed as a Additional Director on 29 Aug 2022 & has been associated with this company since 2 years 8 months .
- Director Appointment
Govina Ramakrishna was appointed as a Director was appointed as a Director on 10 Aug 2009 & has been associated with this company since 15 years 8 months .
- Director Appointment
Indu Govina was appointed as a Director was appointed as a Director on 10 Aug 2009 & has been associated with this company since 15 years 8 months .
- Company Incorporation
Sri Indu Drugs India Private Limited was registered on 10 Aug 2009 with Roc Hyderabad & aged 15 years 8 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Sri Indu Drugs India Private Limited?
Sri Indu Drugs India Private Limited was incorporated on 10 Aug 2009.
What is authorized share capital and paid-up capital of Sri Indu Drugs India Private Limited?
The authorized share capital of Sri Indu Drugs India Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Sri Indu Drugs India Private Limited?
Currently 3 directors are associated with Sri Indu Drugs India Private Limited.
- Govina Ramakrishna
- Indu Govina
- Rahul Tammineedi
What is the registered address of Sri Indu Drugs India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sri Indu Drugs India Private Limited is Plot No. 153/10 Road 22 Vivekananda Nagar Colony, Kukatpally India, Hyderabad, Telangana, 500072.
What is the corporate identification number (CIN) and company number of Sri Indu Drugs India Private Limited?
The corporate identification number (CIN) of Sri Indu Drugs India Private Limited is U24232TG2009PTC064701 and the company number is 064701 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Sri Indu Drugs India Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Sri Indu Drugs India Private Limited has risen by 70.44%.
What change has been observed in the net worth of Sri Indu Drugs India Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Sri Indu Drugs India Private Limited has experienced an upsurge of 421.99%.
When was the last Balance Sheet of Sri Indu Drugs India Private Limited filed with the ROC?
The most recent Balance Sheet for Sri Indu Drugs India Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records